CollPlant Biotechnologies Ltd.
CLGN
$2.42
$0.000.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 10.96M | 10.72M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 10.96M | 10.72M | |
| Cost of Revenue | -- | -- | 1.99M | 1.28M | |
| Gross Profit | -- | -- | 8.97M | 9.44M | |
| SG&A Expenses | -- | -- | 6.00M | 6.55M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 18.47M | 17.84M | |
| Operating Income | -- | -- | -7.51M | -7.12M | |
| Income Before Tax | -- | -- | -7.02M | -6.73M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -7.02 | -6.73 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -7.02M | -6.73M | |
| EBIT | -- | -- | -7.51M | -7.12M | |
| EBITDA | -- | -- | -6.41M | -6.01M | |
| EPS Basic | -- | -- | -0.61 | -0.60 | |
| Normalized Basic EPS | -- | -- | 0.06 | 0.07 | |
| EPS Diluted | -- | -- | -0.63 | -0.62 | |
| Normalized Diluted EPS | -- | -- | 0.05 | 0.06 | |
| Average Basic Shares Outstanding | -- | -- | 45.54M | 45.26M | |
| Average Diluted Shares Outstanding | -- | -- | 45.94M | 45.66M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |